Accurate assessment of kidney function in indigenous Australians: the estimated GFR study.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 22884671)

Published in Am J Kidney Dis on August 09, 2012

Authors

Louise J Maple-Brown1, Jaquelyne T Hughes, Paul D Lawton, Graham R D Jones, Andrew G Ellis, Katrina Drabsch, Alex D H Brown, Alan Cass, Wendy E Hoy, Richard J MacIsaac, Kerin O'Dea, George Jerums

Author Affiliations

1: Menzies School of Health Research, Darwin, Australia. louise.maple-brown@menzies.edu.au

Articles by these authors

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet (2011) 13.10

Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med (2012) 11.83

Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med (2009) 9.77

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet (2010) 6.23

Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet (2009) 4.73

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 4.43

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int (2013) 3.42

Patterns of mortality in Indigenous adults in the Northern Territory, 1998-2003: are people living in more remote areas worse off? Med J Aust (2009) 3.39

How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ (2008) 3.00

Glycemic index and dietary fiber and the risk of type 2 diabetes. Diabetes Care (2004) 2.89

Sustainability science: an integrated approach for health-programme planning. Lancet (2008) 2.73

Alcohol consumption and cardiovascular mortality accounting for possible misclassification of intake: 11-year follow-up of the Melbourne Collaborative Cohort Study. Addiction (2007) 2.72

Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust (2007) 2.68

Cardiovascular risk perception and evidence--practice gaps in Australian general practice (the AusHEART study). Med J Aust (2010) 2.62

The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol (2013) 2.41

Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int (2003) 2.40

Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care (2004) 2.36

An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial. Crit Care Med (2012) 2.27

Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care (2011) 2.27

Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr (2007) 2.26

Biomarkers in chronic kidney disease: a review. Kidney Int (2011) 2.25

Human nephron number: implications for health and disease. Pediatr Nephrol (2011) 2.03

The metabolic syndrome and CVD outcomes for a central Australian cohort. Diabetes Res Clin Pract (2013) 1.97

Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation. Kidney Int (2009) 1.96

Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. J Am Soc Nephrol (2005) 1.95

Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis (2009) 1.94

Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab (2008) 1.90

A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int Suppl (2003) 1.90

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. Diabetes Care (2009) 1.89

Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med (2009) 1.86

Effects of fibrates in kidney disease: a systematic review and meta-analysis. J Am Coll Cardiol (2012) 1.84

The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Med (2008) 1.83

Unrecognized anemia in patients with diabetes: a cross-sectional survey. Diabetes Care (2003) 1.79

Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people? Med J Aust (2005) 1.76

A1C for screening and diagnosis of type 2 diabetes in routine clinical practice. Diabetes Care (2010) 1.76

Proficiency testing/external quality assessment: current challenges and future directions. Clin Chem (2011) 1.75

Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial. J Am Coll Cardiol (2010) 1.74

Patient views about treatment of stage 5 CKD: a qualitative analysis of semistructured interviews. Am J Kidney Dis (2010) 1.74

Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. Eur Heart J (2013) 1.74

Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet (2013) 1.73

Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease? Diabetes Care (2006) 1.70

Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol (2009) 1.68

Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes. Diabetes Care (2008) 1.67

The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients. Perit Dial Int (2009) 1.66

The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ (2012) 1.63

The role of energy cost in food choices for an Aboriginal population in northern Australia. Med J Aust (2009) 1.62

The epidemiology of hemoglobin levels in patients with type 2 diabetes. Am J Kidney Dis (2006) 1.62

Cause of death in patients with end-stage renal disease: assessing concordance of death certificates with registry reports. Aust N Z J Public Health (2003) 1.61

Timing of renal replacement therapy and patient outcomes in the randomized evaluation of normal versus augmented level of replacement therapy study. Crit Care Med (2014) 1.60

Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy. Kidney Int (2010) 1.57

A comparison of nephron number, glomerular volume and kidney weight in Senegalese Africans and African Americans. Nephrol Dial Transplant (2010) 1.56

Access to renal transplantation among American Indians and Hispanics. Am J Kidney Dis (2004) 1.56

Dietary patterns and diabetes incidence in the Melbourne Collaborative Cohort Study. Am J Epidemiol (2007) 1.53

Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia. Kidney Int (2012) 1.53

Preoperative estimates of glomerular filtration rate as predictors of outcome after surgery: a systematic review and meta-analysis. Anesthesiology (2013) 1.51

Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study). Nephrol Dial Transplant (2011) 1.50

The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology (Carlton) (2009) 1.48

Socioeconomic disparities in stroke rates and outcome: pooled analysis of stroke incidence studies in Australia and New Zealand. Med J Aust (2011) 1.48

Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant (2013) 1.47

Early acid-base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis. Intensive Care Med (2013) 1.46

Increased arterial stiffness in remote Indigenous Australians with high risk of cardiovascular disease. J Hypertens (2007) 1.46

Deficiency in the detection of microalbuminuria by urinary dipstick in diabetic patients. Diabetes Care (2003) 1.45

Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J Am Soc Nephrol (2010) 1.45

Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis. Intensive Care Med (2013) 1.44

Gaps in cardiovascular disease risk management in Australian general practice. Med J Aust (2009) 1.42

Epidemiology of RBC Transfusions in Patients With Severe Acute Kidney Injury: Analysis From the Randomized Evaluation of Normal Versus Augmented Level Study. Crit Care Med (2016) 1.42

Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement. Med J Aust (2012) 1.40

The effect of ramipril on albumin excretion in diabetes and hypertension: the role of increased lysosomal activity and decreased transforming growth factor-beta expression. J Hypertens (2003) 1.39

How fair is Medicare? The income-related distribution of Medicare benefits with special focus on chronic care items. Med J Aust (2012) 1.39

Urinary proteomics for early diagnosis in diabetic nephropathy. Diabetes (2012) 1.38

Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care (2009) 1.37

Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations. Med J Aust (2012) 1.36

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes (2002) 1.36

Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. Eur Heart J (2010) 1.34

The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J (2003) 1.33

Accelerated maturation and abnormal morphology in the preterm neonatal kidney. J Am Soc Nephrol (2011) 1.31

Determinants of glomerular volume in different cortical zones of the human kidney. J Am Soc Nephrol (2005) 1.31

Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study. J Am Soc Nephrol (2007) 1.31

Diabetic kidney disease with and without albuminuria. Curr Opin Nephrol Hypertens (2011) 1.31

Associations of glomerular number and birth weight with clinicopathological features of African Americans and whites. Am J Kidney Dis (2008) 1.30

Cardiovascular disease risk management for Aboriginal and Torres Strait Islander peoples in primary health care settings: findings from the Kanyini Audit. Med J Aust (2009) 1.28

Ten principles relevant to health research among Indigenous Australian populations. Med J Aust (2012) 1.28

Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy. J Am Soc Nephrol (2004) 1.28

Lower than expected morbidity and mortality for an Australian Aboriginal population: 10-year follow-up in a decentralised community. Med J Aust (2008) 1.27

Community preferences for the allocation of solid organs for transplantation: a systematic review. Transplantation (2010) 1.26

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society Of Infectious Diseases Pharmacists. Clin Biochem Rev (2010) 1.24

Proteinuria and stroke: a meta-analysis of cohort studies. Am J Kidney Dis (2008) 1.22

Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy. Diabetes Care (2003) 1.22

Plasma phospholipid fatty acid composition as a biomarker of habitual dietary fat intake in an ethnically diverse cohort. Nutr Metab Cardiovasc Dis (2006) 1.22

Study protocol--diabetes and related conditions in urban indigenous people in the Darwin, Australia region: aims, methods and participation in the DRUID Study. BMC Public Health (2006) 1.19

Integrating albuminuria and GFR in the assessment of diabetic nephropathy. Nat Rev Nephrol (2009) 1.19